PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.00%
Revenue growth above 1.5x RUN's 12.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.01%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
74.46%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
32.20%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
146.08%
Net income growth under 50% of RUN's 460.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
162.24%
EPS growth under 50% of RUN's 456.14%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
144.76%
Diluted EPS growth under 50% of RUN's 436.85%. Michael Burry would worry about an eroding competitive position or excessive dilution.
4.71%
Share count expansion well above RUN's 1.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.00%
Diluted share count expanding well above RUN's 1.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-431.41%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1092.57%
Negative FCF growth while RUN is at 156.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
9.37%
10Y revenue/share CAGR under 50% of RUN's 231.43%. Michael Burry would suspect a lasting competitive disadvantage.
9.37%
5Y revenue/share CAGR under 50% of RUN's 64.82%. Michael Burry would suspect a significant competitive gap or product weakness.
9.37%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
82.72%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
82.72%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
82.72%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
107.35%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
107.35%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
107.35%
Below 50% of RUN's 220.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
33.66%
AR growth well above RUN's 8.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
33.95%
Inventory growth well above RUN's 18.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.31%
Asset growth at 50-75% of RUN's 4.18%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-0.35%
We have a declining book value while RUN shows 11.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
339.16%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
5.58%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.